NASDAQ$BIOLQ
Biolase Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Reported 26% revenue growth year over year.
BIOLASE, Inc. announced its financial results for the third quarter ended September 30, 2022, with total revenue of $12.0 million, up 26% year over year. U.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year. The company is increasing its 2022 full year revenue guidance and now expects full year net revenue to increase at least 20% from 2021 levels.
- Total revenue was $12.0 million, up 26% year over year
- U.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year, driven by increased procedures using BIOLASE lasers
- Over 90% of U.S. Waterlase sales coming from new customers and approximately 40% of U.S. Waterlase sales coming from dental specialists
- Waterlase Exclusive Trial Program success rate remained at over 50% year to date, highlighting the program’s success
Headline financials
Revenue & EPS history
Biolase · Revenue · Quarterly
$12M
Revenue by segment
Biolase · $6.7M total across 2 segments · Q3 2023
- US Laser Revenue$3.8M-17.4%56.7%
- International Laser Revenue$2.9M—43.3%
Forward guidance
BIOLASE is anticipating fourth quarter net revenue to exceed $13.0 million, which would represent growth of at least 5% year over year. The Company is increasing its 2022 full year revenue guidance and now expects full year net revenue to increase at least 20% from 2021 levels.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
-3.0%
Avg return
Earnings day
-6.6%
Avg return
5 days after
-13.5%
Avg return
30 days after
41%
24 / 58 earnings
Positive
+25.4%
Q2 2021
Best reaction
-45.7%
Q1 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2024 | -18.9% | -9.9% | +26.1% | |
| Q2 2024 | +7.8% | -10.0% | -30.0% | |
| Q1 2024 | +1.8% | -10.8% | -21.9% | |
| Q4 2024 | +20.3% | +7.5% | -6.8% | |
| Q3 2023 | -22.0% | -17.3% | -23.4% | |
| Q2 2023 | -19.5% | -6.2% | -50.2% | |
| Q1 2023 | -6.7% | -15.4% | -17.4% | |
| Q4 2022 | -10.8% | -24.8% | -43.8% | |
| Q3 2022 | +16.3% | +27.7% | -49.2% | |
| Q2 2022 | -1.1% | -5.3% | -33.6% | |
| Q1 2022 | +0.0% | -2.0% | -47.1% | |
| Q4 2021 | +2.9% | +4.1% | -9.3% | |
| Q3 2021 | -8.2% | -17.9% | -34.5% | |
| Q2 2021 | +25.4% | +5.7% | +10.0% | |
| Q1 2021 | -1.2% | -1.5% | -10.8% | |
| Q3 2020 | -3.3% | -10.4% | -0.8% | |
| Q2 2020 | -2.4% | -4.7% | -28.9% | |
| Q1 2020 | -45.7% | -49.0% | -6.0% | |
| Q4 2019 | -22.4% | -52.1% | -7.3% | |
| Q3 2019 | -5.8% | +6.3% | +2.9% | |
| Q2 2019 | -7.7% | -12.3% | -36.1% | |
| Q1 2019 | +2.5% | -8.4% | -13.9% | |
| Q4 2018 | -16.5% | -18.0% | -21.6% | |
| Q3 2018 | -9.3% | -9.3% | -27.9% | |
| Q2 2018 | +9.5% | +29.9% | +60.6% | |
| Q1 2018 | -2.4% | +1.1% | -13.1% | |
| Q4 2017 | -4.1% | -7.8% | -36.7% | |
| Q3 2017 | +0.0% | +0.0% | -25.0% | |
| Q2 2017 | -29.8% | -32.3% | -28.8% | |
| Q1 2017 | -3.8% | -3.0% | -3.8% | |
| Q4 2016 | -2.5% | -4.2% | +5.8% | |
| Q3 2016 | +20.8% | +20.1% | +18.8% | |
| Q2 2016 | +1.8% | +12.4% | +56.6% | |
| Q1 2016 | -12.3% | — | — | |
| Q4 2015 | -0.8% | — | — | |
| Q3 2015 | +8.5% | — | — | |
| Q2 2015 | +6.3% | — | — | |
| Q1 2015 | +1.0% | — | — | |
| Q4 2014 | -2.5% | — | — | |
| Q3 2014 | -3.3% | — | — | |
| Q2 2014 | +1.4% | — | — | |
| Q1 2014 | -0.8% | — | — | |
| Q4 2013 | +0.7% | — | — | |
| Q3 2013 | -11.8% | — | — | |
| Q2 2013 | -22.7% | — | — | |
| Q1 2013 | +3.5% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +10.6% | — | — | |
| Q2 2012 | -1.2% | — | — | |
| Q1 2011 | +0.8% | — | — | |
| Q1 2012 | +1.8% | — | — | |
| Q4 2011 | +0.5% | — | — | |
| Q4 2009 | +0.5% | — | — | |
| Q3 2011 | +4.9% | — | — | |
| Q3 2010 | +4.9% | — | — | |
| Q2 2010 | -10.2% | — | — | |
| Q4 2010 | -10.2% | — | — | |
| Q2 2011 | -10.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro